Medicine and Dentistry
Patient
100%
Non Small Cell Lung Cancer
60%
Programmed Death 1 Ligand 1
37%
Lung Cancer
36%
Overall Survival
27%
Programmed Cell Death
25%
Neoplasm
24%
Lung Adenocarcinoma
24%
Immune Checkpoint Inhibitor
21%
Surgery
21%
Ligand
20%
Epidermal Growth Factor Receptor
19%
Adenocarcinoma
18%
Inpatient
16%
Nutritional Status
14%
Pneumonectomy
13%
Smoking
13%
Small Cell Lung Cancer
12%
Recurrence Free Survival
12%
Survival
11%
Therapeutic Procedure
11%
Prognostic Factor
11%
Disease Free Survival
10%
Skeletal Muscle
10%
Association
10%
Predictor
10%
Albumin
10%
C Reactive Protein
10%
Geriatrics
8%
Computer Assisted Tomography
8%
Hazard Ratio
8%
Analysis
8%
Serum
7%
Cells
7%
Diagnosis
7%
Biological Marker
7%
Atezolizumab
7%
Multivariate Analysis
6%
Lesion
6%
Squamous Cell Lung Carcinoma
6%
Monotherapy
6%
Metastatic Carcinoma
6%
Lymphocyte
6%
Prognosis
6%
Malignant Neoplasm
5%
Blister
5%
Lobectomy
5%
Log Rank Test
5%
Elderly Patient
5%
Brain Metastasis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
20%
Ligand
15%
Programmed Death 1 Ligand 1
10%
Immune Checkpoint Inhibitor
9%
Lung Cancer
9%
Prognosis
8%
Programmed Cell Death
8%
Albumin
7%
Atezolizumab
7%
Lung Adenocarcinoma
7%
Neoplasm
7%
Adenocarcinoma
6%
Overall Survival
6%
C Reactive Protein
6%
Survival
5%
Lung Adenocarcinoma
5%